Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.560
-0.060 (-2.29%)
Oct 6, 2026, 12:20 PM EDT - Market open
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $443.24 million as of October 6, 2026. Its market cap has increased by 410.65% in one year.
Market Cap
443.24M
Enterprise Value
432.36M
1-Year Change
410.65%
Ranking
Category
Stock Price
$2.56
ChartMarket Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.40M to $443.24M, an increase of 520.79%. That is a compound annual growth rate of 24.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 443.24M | 398.03% |
| Dec 31, 2025 | 89.00M | 13.96% |
| Dec 31, 2024 | 78.10M | 351.45% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.50% |
| Dec 31, 2018 | 34.90M | -51.12% |
| Jun 28, 2018 | 71.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 520.34M |
| ProKidney | 519.99M |
| Allogene Therapeutics | 518.24M |
| Neurogene | 513.29M |
| Contineum Therapeutics | 493.59M |
| Puma Biotechnology | 490.91M |
| REGENXBIO | 490.48M |
| Bright Minds Biosciences | 488.45M |